Search

everythinglearnresearchcommunity

for

Search:↓

Post-COVID-19 hair loss is likely due to stress and inflammation.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.

COVID-19 can cause temporary hair loss.

COVID-19 can cause a temporary hair loss condition.

Most children with rapid hair loss had a known cause, with stress and illness being top triggers, and treatments showed similar improvement.

A horse's sudden hair loss was caused by an allergic reaction to a coat conditioning powder.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Anesthesia and surgery can cause temporary hair loss, but hair usually grows back without treatment.

Most Iraqi women with telogen effluvium did not have a clear cause for their hair loss, and few had significant thinning.

Critically ill patients may experience temporary hair loss after a fever.

Some drugs can cause temporary or permanent hair loss.

A 17-year-old girl has had repeated hair loss since childhood, which can be triggered by infections like COVID-19.

Most Iraqi women with telogen effluvium had no clear cause for their hair loss, and few had significant thinning.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Modern therapies, like fractional laser, effectively treat telogen effluvium.

COVID-19 may cause hair loss months after infection.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

The debate focuses on the role of catagen and hair shedding mechanisms in telogen effluvium.

The conclusion is that three signs can help diagnose hair loss after it happens, potentially avoiding more invasive tests.

The document's conclusion cannot be provided because the document cannot be parsed.

COVID-19 infection may cause hair loss.

Hair transplant surgery can cause temporary hair loss in the area where hair was taken from.

Hair loss might be the first sign of dengue fever.

The document concludes that a new treatment for a type of hair loss called telogen effluvium was tested and shows promise.

Hair loss from telogen effluvium may not happen again after another surgery.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

A 6-year-old girl experienced temporary hair loss after mild COVID-19, which improved naturally in 8 months.

Emotional stress can trigger intermittent hair loss in chronic telogen effluvium, which may not improve with treatment if stress continues.